Eli Lilly (Brazil) Analysis

LILY34 Stock  BRL 180.70  5.96  3.41%   
Eli Lilly and is undervalued with Real Value of 202.73 and Hype Value of 180.7. The main objective of Eli Lilly stock analysis is to determine its intrinsic value, which is an estimate of what Eli Lilly and is worth, separate from its market price. There are two main types of Eli Lilly's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Eli Lilly's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Eli Lilly's stock to identify patterns and trends that may indicate its future price movements.
The Eli Lilly stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Eli Lilly's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Eli Stock Analysis Notes

The company has Price/Earnings To Growth (PEG) ratio of 2.07. Eli Lilly last dividend was issued on the 14th of February 2023. The entity had 1:15 split on the 20th of November 2022. Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. LILLY DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 34690 people. To find out more about Eli Lilly and contact Jacob Naarden at 317 276 2000 or learn more at https://www.lilly.com.

Eli Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.82 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eli Lilly's market, we take the total number of its shares issued and multiply it by Eli Lilly's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Eli Profitablity

Eli Lilly's profitability indicators refer to fundamental financial ratios that showcase Eli Lilly's ability to generate income relative to its revenue or operating costs. If, let's say, Eli Lilly is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Eli Lilly's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Eli Lilly's profitability requires more research than a typical breakdown of Eli Lilly's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

Technical Drivers

As of the 2nd of March, Eli Lilly shows the Coefficient Of Variation of 639.27, mean deviation of 1.81, and Downside Deviation of 2.17. In respect to fundamental indicators, the technical analysis model provides you with a way to check existing technical drivers of Eli Lilly, as well as the relationship between them.

Eli Lilly Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Eli Lilly middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Eli Lilly. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Eli Lilly Outstanding Bonds

Eli Lilly issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eli Lilly uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eli bonds can be classified according to their maturity, which is the date when Eli Lilly and has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Eli Lilly Predictive Daily Indicators

Eli Lilly intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eli Lilly stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Eli Lilly Forecast Models

Eli Lilly's time-series forecasting models are one of many Eli Lilly's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eli Lilly's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Eli Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eli Lilly prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eli shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eli Lilly. By using and applying Eli Stock analysis, traders can create a robust methodology for identifying Eli entry and exit points for their positions.
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. LILLY DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 34690 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Eli Lilly to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites